Zoetis Inc. (ZTS) Announces Earnings Results

Zoetis Inc. (NYSE:ZTS) posted its quarterly earnings data on Thursday. The company reported $0.65 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.63 by $0.02, Bloomberg Earnings reports. The firm had revenue of $1.35 billion during the quarter, compared to the consensus estimate of $1.32 billion. Zoetis had a net margin of 17.50% and a return on equity of 62.49%. The business’s revenue for the quarter was up 8.5% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.52 EPS. Zoetis updated its FY17 guidance to $2.34-$2.39 EPS.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 1st. Investors of record on Thursday, November 9th will be issued a dividend of $0.105 per share. The ex-dividend date is Wednesday, November 8th. This represents a $0.42 dividend on an annualized basis and a yield of 0.62%. Zoetis’s dividend payout ratio (DPR) is presently 23.73%.

ZTS has been the subject of several analyst reports. Cowen and Company set a $60.00 target price on shares of Zoetis and gave the company a “buy” rating in a research report on Tuesday, July 11th. Deutsche Bank AG restated a “buy” rating and issued a $65.00 target price (up from $62.00) on shares of Zoetis in a research report on Monday, July 17th. Stifel Nicolaus restated a “buy” rating and issued a $65.00 target price on shares of Zoetis in a research report on Friday, July 21st. Goldman Sachs Group, Inc. (The) restated a “neutral” rating and issued a $62.00 target price on shares of Zoetis in a research report on Monday, August 7th. Finally, Cantor Fitzgerald set a $75.00 target price on shares of Zoetis and gave the company a “buy” rating in a research report on Monday, August 14th. Two investment analysts have rated the stock with a sell rating, five have assigned a hold rating and eleven have issued a buy rating to the company. The stock currently has a consensus rating of “Buy” and an average target price of $65.76.

TRADEMARK VIOLATION WARNING: This news story was reported by Community Financial News and is owned by of Community Financial News. If you are viewing this news story on another publication, it was copied illegally and reposted in violation of United States and international trademark & copyright legislation. The legal version of this news story can be viewed at https://www.com-unik.info/2017/11/02/zoetis-inc-zts-announces-quarterly-earnings-results.html.

Zoetis Company Profile

Zoetis Inc is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company has a business, commercializing products across eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock) and dogs, cats and horses (collectively, companion animals), and within five product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals.

Earnings History for Zoetis (NYSE:ZTS)

What are top analysts saying about Zoetis Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Zoetis Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit